Drugs / Human cord tissue mesenchymal stromal cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04399889 | Jun 2020 → Feb 2022 | COVID-19 | Joanne Kurtzberg, MD | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human cord tissue mesenchymal stromal cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04399889 ↗ |
| Route | Intravenous | “intravenous administration of allogenic human cord tissue mesenchymal stromal cells (hCT-MSC)” NCT04399889 ↗ |